Article

BioPharm International Multimedia

Cell Therapies

Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about emerging trends in cell therapy.

Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about emerging trends in cell therapy. 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
September 17th 2025

CSL Backs Late-Stage Development of VarmX’s Coagulation Therapy VMX-C001X

Feliza Mirasol
Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image Credit: © pinkeyes - © pinkeyes - stock.adobe.com
September 17th 2025

Limula’s LimONE System Targets Consistency in Stem Cell Transplants

Feliza Mirasol
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 17th 2025

Monte Rosa and Novartis Partner to Target Undruggable Immunology Pathways with Degraders

Feliza Mirasol
Gene Therapy for Cancer Treatment Concept Cancer therapy with T-cell and pipette | Image Credit: © catalin - © catalin - stock.adobe.com
September 17th 2025

€10.7 Million Investment Accelerates Gene Writing and CAR-T Preclinical Development

Feliza Mirasol
We have to stick to the facts. a group of scientists working together in a lab. | Image Credit: © Courtney H/peopleimages.com - © Courtney H/peopleimages.com - stock.adobe.com
September 17th 2025

Stem Cell Community Day 2025 to Focus on Process Engineering and Scale-Up Innovation

Feliza Mirasol
Ribosome translating mRNA into a polypeptide chain | Image Credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com
September 17th 2025

Quotient Sciences and CPI Target Faster RNA-Based Drug Development

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.